NCT01762592 REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT Status WITHDRAWN Phase PHASE3
NCT01751529 Open-label Pilot Evaluating Renal Lesions w/ Contrast-enhaced US in Patients w/ Renal Cancer Status COMPLETED Phase EARLY_PHASE1
NCT01576211 Studying Genes Using Cord Blood and Placenta Samples From Relatively Healthy Newborns and Samples From Younger Patients With Wilms Tumor Status COMPLETED Phase N/A
NCT01576198 Studying Biomarkers in Samples From Younger Patients With Wilms Tumor Status COMPLETED Phase N/A
NCT01553175 Studying Gene Expression in Samples From Patients With Rhabdoid Tumors Status COMPLETED Phase N/A
NCT01544569 Studying Biomarkers in Samples From Young Patients With Rhabdoid Tumors Status COMPLETED Phase N/A
NCT01542333 Studying Biomarkers in Samples From Younger Patients With Wilms Tumor Status COMPLETED Phase N/A
NCT01497444 Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery Status COMPLETED Phase PHASE1
NCT01486550 Hydroxyethyl Starch and Renal Function After Laparoscopic Nephrectomy Status TERMINATED Phase PHASE4
NCT01447199 The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC) Status UNKNOWN Phase N/A
NCT01392183 Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) Status COMPLETED Phase PHASE2
NCT01353300 Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer Status COMPLETED Phase N/A
NCT01314391 Biomarkers in Blood and Tumor Tissue Samples From Patients With Wilms Tumor Status COMPLETED Phase N/A
NCT01264341 Efficacy and Safety of Bevacizumab/Temsirolimus Combination to Treat Advanced Renal Cell Carcinoma Status TERMINATED Phase PHASE2
NCT01263769 Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC) Status COMPLETED Phase PHASE2
NCT01230697 Perspective Evaluation of Hormones Involved in Serum Phosphate Homeostasis in Patients With Metastatic Renal Cells Carcinoma or Hepatocellular Carcinoma Treated With Sorafenib (SORHORM) Status UNKNOWN Phase N/A
NCT01217931 Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial Status ACTIVE_NOT_RECRUITING Phase PHASE2